InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
p0 Free
03/27/24 5:33 AM
profile icon
p0 Free
03/20/24 2:42 AM
profile icon
p0 Free
02/29/24 5:33 AM
profile icon
p0 Free
02/15/24 5:43 AM
profile icon
p0 Free
02/05/24 2:48 AM
profile icon
Mountainman5 Free
01/30/24 8:56 AM
Bullish
Bullish
profile icon
p0 Free
01/11/24 4:16 AM
profile icon
Mountainman5 Free
12/30/23 6:06 AM
Bearish
Bearish
profile icon
p0 Free
12/04/23 5:24 PM
profile icon
p0 Free
12/04/23 3:12 AM
profile icon
p0 Free
11/27/23 2:46 AM
profile icon
p0 Free
11/24/23 5:25 AM
profile icon
p0 Free
11/14/23 5:05 AM
profile icon
p0 Free
11/10/23 10:33 AM
profile icon
p0 Free
10/25/23 1:56 PM
profile icon
p0 Free
09/21/23 6:00 AM
profile icon
p0 Free
09/15/23 1:12 PM
profile icon
p0 Free
09/04/23 5:21 AM
profile icon
p0 Free
08/30/23 8:25 AM
profile icon
p0 Free
08/28/23 1:09 AM
profile icon
p0 Free
06/13/23 5:12 AM
profile icon
p0 Free
05/04/23 2:18 PM
profile icon
p0 Free
03/30/23 3:23 AM
profile icon
p0 Free
03/02/23 7:55 AM
profile icon
p0 Free
02/20/23 2:38 AM
profile icon
p0 Free
02/17/23 2:37 AM
profile icon
p0 Free
02/15/23 4:46 PM
profile icon
p0 Free
02/05/23 2:27 PM
profile icon
p0 Free
12/23/22 6:13 AM
profile icon
p0 Free
12/21/22 3:09 PM
profile icon
p0 Free
12/01/22 7:56 AM
profile icon
p0 Free
11/29/22 3:24 PM
profile icon
p0 Free
11/17/22 5:51 AM
profile icon
p0 Free
11/10/22 3:35 AM
profile icon
p0 Free
10/10/22 2:43 AM
profile icon
p0 Free
10/05/22 6:08 AM
profile icon
p0 Free
10/04/22 4:49 PM
profile icon
p0 Free
09/26/22 3:55 AM
profile icon
p0 Free
09/08/22 10:18 AM
profile icon
p0 Free
09/06/22 5:43 AM
profile icon
p0 Free
08/29/22 3:06 AM
profile icon
p0 Free
08/24/22 1:40 AM
profile icon
p0 Free
08/23/22 12:57 PM
profile icon
p0 Free
08/19/22 4:42 AM
profile icon
p0 Free
08/18/22 2:49 AM
profile icon
p0 Free
08/11/22 3:43 AM
profile icon
p0 Free
08/10/22 4:56 AM
profile icon
p0 Free
08/08/22 9:00 AM

Valneva SE (VALN) RSS Feed

Followers
3
Posters
4
Posts (Today)
0
Posts (Total)
153
Created
07/25/18
Type
Free
Moderators

Valneva Pipeline - https://valneva.com/research-development/ ||  DEV > https://www.valneva.at/en/general-public


Lyme disease – VLA15 is the most common vector-borne illness in the Northern Hemisphere. Valneva's candidate is the only vaccine in clinical development worldwide. Valneva´s vaccine candidate VLA15, under Fast Track Designation by the FDA, is a multivalent vaccine that targets the outer surface protein A (OspA) of Borrelia.
Chikungunya  – VLA1553 is a mosquito-borne viral infection spreading in the Americas and Europe caused by the chikungunya virus (CHIKV), a Togaviridae virus transmitted by Aedes mosquitoes. Valneva’s vaccine candidate VLA1553, under Fast Track Designation by the FDA, is a monovalent, single dose, live-attenuated vaccine candidate against chikungunya.
COVID-19VLA2001. COVID-19 has caused millions of deaths globally and has been declared a pandemic by the World Health Organization (WHO). To help fight the pandemic, Valneva has developed VLA2001, currently the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe.
Zika – VLA1601. A mosquito-borne disease associated with birth defects. Since 1952, Zika outbreaks have been reported in tropical Africa, Southeast Asia, the Pacific Islands, and, in 2015, in the Americas. Valneva’s vaccine candidate, VLA1601, is a highly purified inactivated vaccine candidate against the Zika virus, developed using the same manufacturing platform as Valneva’s Japanese encephalitis vaccine.
Clostridium difficile – VLA84. Clostridium difficile is a bacterium that causes diarrhea and sometimes can lead to serious intestinal conditions or complications. Valneva’s prophylactic vaccine candidate against C. difficile infection, VLA84, successfully completed Phase 2 development and is Phase 3 ready.

STATUS: 12/2021


   T W I T T E R   https://twitter.com/valnevaSE
 
Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post